Request Your Free Playbook Now:

"Leveraging Real-World Data for Successful Biosimilar Launch Strategies"

This playbook explains how to use real-world data to develop and launch new biosimilars, achieve commercial success and capture a chunk of this lucrative market.

The biosimilars market is projected to grow to $100 billion by 2029—and as these drugs continue to steadily grab a bigger and bigger part of market share, they’re transforming healthcare and providing more affordable alternatives to complex biologic drugs.

With the demand for biosimilars growing exponentially, real-world data holds the key to getting the competitive edge you need to successfully bring these critical therapies to market. After reading this playbook, you'll have a firm understanding of how you can use real-world data to identify:

• The data sets that can support effective launch planning
• Stakeholders who can maximize your product opportunity
• Gaps in the current diagnosis, referral, treatment, and reimbursement landscapes that can be addressed by a new product  
• Insights that inform strategies and tactics throughout the product lifecycle

Offered Free by: BioPharma Dive's studioID and Komodo Health
See All Resources from: BioPharma Dive's studioID and Komodo Health